Conquer Cancer, the ASCO Foundation

What it reported doing in 2024

See schedule o: research: research is how we conquer cancer. It means everything, from understanding how cancer impacts certain people to finding groundbreaking new ways to treat cancer. The conquer cancer grants & awards program has been recognizing excellence in clinical research, quality care, and teaching in the field of oncology since 1984, when the program originally began under the purview of asco. Conquer cancer funds the entire spectrum of research activities related to cancer prevention, screening, treatment, and outcomes research in all cancer types, and supports progress by funding cancer researchers at all stages of their careers, enabling oncology's best and brightest to pursue promising research. Conquer cancer and asco have funded more than $191 million to support grants & awards to over 9,300 recipients in 90 countries. Highlights of 2024 research activities and accomplishments include: *advanced clinical research award (acra): $1,350,000 provided three (3) three-year awards to physician-scientists committed to support clinical cancer research with a patient-oriented focus. Awards supported focused on breast cancer research. *career development award (cda): $4,200,000 provided twenty-one (21) three-year awards intended to support clinical research of clinical investigators who have received their initial faculty appointments and are establishing independent clinical cancer research programs. *young investigator award (yia): $4,560,000 provided ninety-one (91) one-year awards designed to encourage and promote high-quality research in clinical oncology by supporting the research of promising investigators during the transition from a fellowship program to a faculty appointment. *global oncology young investigator award: $300,000 provided five (6) one-year awards to early-career investigators to support research in global oncology and to develop the next generation of researchers to address global health needs. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. *international innovation grant: $39,500 provided two (2) one-year awards in support of novel and innovative projects that have the potential to reduce the cancer burden in local communities, while also being potentially transferrable to other low- or middle- income settings. *long-term international fellowship: $115,000 provided one (1) one year grant whichenables an early career member oncologist in a low to middle income country and their mentor in the united states or canada to extend the collaboration through a research fellowship at the mentor's institution.through its everygrant program, conquer cancer utilizes its skills and expertise in grants administration and program management to collaborate with other organizations to develop and deliver programs that make a difference to cancer care teams and patients everywhere.

Financial Efficiency

• Mission deployment rate: 60.6%; rating input score 61
• Program expense ratio: 66.8%; rating input score 67
• Fundraising efficiency: $3.77 raised per $1 spent on fundraising; rating input score 15; 15th percentile among comparable filings

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 62nd percentile among comparable filings
• Pay-setting controls: 0 of 6 controls in place; rating input score 0
  • Compensation committee: Missing
  • Independent consultant: Missing
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Missing
  • Board or committee approval: Missing
• Foreign activity oversight: 5 of 8 controls in place; rating input score 62
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Pass
  • Conducts field audits: Limited
  • May suspend future funding: Limited
  • Requires financial reports: Pass
  • Conducts site visits: Limited
  • Requires grant agreements: Pass
  • May require repayment: Pass
• Grant itemization coverage: 100%; rating input score 100; 42nd percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 95.2%; rating input score 95; 29th percentile among comparable filings
• Governance controls: 7 of 9 controls in place; rating input score 78
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Fail
  • Other executive compensation review process: Fail
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 16.1%; rating input score 78; 78th percentile among comparable filings
• Total-asset coverage ratio: 3.47; rating input score 78; 78th percentile among comparable filings
• Liabilities to assets ratio: 0.1; rating input score 73; 73rd percentile among comparable filings
• Officer compensation ratio: 0.3%; rating input score 91; 91st percentile among comparable filings

Growth

• Program expense growth: 1.8% per year; rating input score 100; 18th percentile among comparable filings
• Revenue growth: 2.7% per year; rating input score 100; 23rd percentile among comparable filings
• Asset growth: 8.2% per year; rating input score 100; 56th percentile among comparable filings